Per Med

• 

  Publication Venue For

  • Development of Competency-based Online Genomic Medicine Training (COGENT). 2022
  • Conference Report: NHGRI Research Training and Career Development Annual Meeting. 2022
  • A precision medicine approach to stress testing using metabolomics and microribonucleic acids..  19:287-297. 2022
  • Welcome to the 18th volume of Personalized Medicine..  18:1-3. 2021
  • Individualizing pharmacogenomic test results in the context of the microbiome..  17:459-468. 2020
  • The enduring importance of family health history in the era of genomic medicine and risk assessment..  17:229-239. 2020
  • Affiliate network members as force amplifiers of genomic medicine research..  16:431-433. 2019
  • What will it take to implement genomics in practice? Lessons from the IGNITE Network..  16:259-261. 2019
  • Educating healthcare providers in the delivery of genomic medicine..  16:187-188. 2019
  • A note from the editors..  15:237-238. 2018
  • Beyond the Genetic Information Nondiscrimination Act: ethical and economic implications of the exclusion of disability, long-term care and life insurance..  14:153-157. 2017
  • Update: looking beyond the 100,000 Genome Project..  14:85-87. 2017
  • Family health history: an essential starting point for personalized risk assessment and disease prevention..  13:499-510. 2016
  • Precision medicine: beyond genomics to targeted therapies..  13:97-100. 2016
  • Should women at high risk for cancer use oral contraceptive pills?.  12:533-535. 2015
  • Interprofessional education for personalized medicine through technology-based learning..  12:237-243. 2015
  • The future of genomic testing in primary care: the changing face of personalized medicine..  11:477-486. 2014
  • Personalized medicine 2014: has healthcare been transformed?.  11:365-368. 2014
  • Translational informatics in personalized medicine: an update for 2014..  11:339-349. 2014
  • 100k Genome Project: sequencing and much more..  10:761-764. 2013
  • Clinical utility of genetic risk testing in primary care: the example of Type 2 diabetes..  10:549-563. 2013
  • The genomic medicine model: an integrated approach to implementation of family health history in primary care..  10:295-306. 2013
  • Building the evidentiary framework for pharmacogenetic testing: is it time to move beyond randomized controlled trials?.  10:1-3. 2013
  • Challenges and opportunities in implementing pharmacogenomics testing in the clinics..  9:609-619. 2012
  • Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact?.  9:565-567. 2012
  • Conference Scene: Is personalized medicine ready for prime time?.  9:475-478. 2012
  • Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare..  9:85-91. 2012
  • Individualized smoking cessation treatment: roles for sets of genomic markers..  8:119-121. 2011
  • Comparative effectiveness research and genomic personalized medicine..  7:223-227. 2010
  • Using genetic information to select treatment for patients with heart failure: has the time come?.  6:385-392. 2009
  • The Center for Genomic Medicine at the Duke Institute for Genome Sciences & Policy: propelling genomics into clinical practice..  6:255-261. 2009
  • Proposal for a new health record to support personalized, predictive, preventative and participatory medicine..  5:47-54. 2008
  • Genomics-based labeling and attribution: a case for integrating social sciences into personalized medicine research..  3:317-323. 2006
  • The future may be closer than you think: a response from the Personalized Medicine Coalition to the Royal Society's report on personalized medicine..  3:119-123. 2006